欧盟EMA药品数据库-欧盟集中审批药品
（European Medicines Agency Authorisation of Medicines DataBase）
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
*Search by Medicine name,INN,Active substance,Product number.
高级搜索
数据记录共 2489 条，共 125 页，当前第 1 页
可点击列名称排序
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Imuldosa Human ustekinumab ustekinumab EMEA/H/C/006221 Accord Healthcare S.L.U. 2024/12/12 Authorised
Absimky Human ustekinumab ustekinumab EMEA/H/C/006585 Accord Healthcare S.L.U. 2024/12/12 Authorised
Theralugand Human lutetium (177Lu) chloride lutetium (177Lu) chloride EMEA/H/C/005882 Eckert & Ziegler Radiopharma GmbH 2024/11/22 Authorised
Hympavzi Human marstacimab marstacimab EMEA/H/C/006240 Pfizer Europe MA EEIG  2024/11/18 Authorised
Fluad Human influenza vaccine (surface antigen, inactivated, adjuvanted) A/(H1N1)-like virus antigen,A/(H3N2)-like virus antigen,B (Victoria lineage)-like virus antigen EMEA/H/C/006538 Seqirus Netherlands B.V. 2024/11/15 Authorised
Flucelvax Human influenza vaccine (surface antigen, inactivated, prepared in cell cultures) A/(H1N1)-like virus antigen,A/(H3N2)-like virus antigen,B (Victoria lineage)-like virus antigen EMEA/H/C/006532 Seqirus Netherlands B.V. 2024/11/15 Authorised
Penbraya Human Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed) Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group W polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group B fHBP protein subfamily A;Neisseria meningitidis group B fHBP protein subfamily B EMEA/H/C/006165 Pfizer Europe MA EEIG  2024/11/14 Authorised
Elahere Human mirvetuximab soravtansine mirvetuximab soravtansine EMEA/H/C/005036 AbbVie Deutschland GmbH & Co. KG 2024/11/14 Authorised
Pomalidomide Teva Human pomalidomide Pomalidomide EMEA/H/C/006302 Teva GmbH 2024/11/14 Authorised
Opuviz Human aflibercept aflibercept EMEA/H/C/006056 Samsung Bioepis NL B.V. 2024/11/13 Authorised
Yuvanci Human macitentan;tadalafil Macitentan;tadalafil EMEA/H/C/005001 Janssen-Cilag International NV 2024/09/27 Authorised
Fymskina Human ustekinumab ustekinumab EMEA/H/C/005805 Formycon AG 2024/09/25 Authorised
Otulfi Human ustekinumab ustekinumab EMEA/H/C/006544 Fresenius Kabi Deutschland GmbH 2024/09/25 Authorised
Axitinib Accord Human axitinib axitinib EMEA/H/C/006206 Accord Healthcare S.L.U. 2024/09/19 Authorised
Vevizye Human ciclosporin ciclosporin EMEA/H/C/006250 Laboratoires Théa 2024/09/19 Authorised
Ranibizumab Midas Human ranibizumab ranibizumab EMEA/H/C/006528 Midas Pharma GmbH 2024/09/19 Authorised
Tuznue Human trastuzumab trastuzumab EMEA/H/C/006252 Prestige Biopharma Belgium 2024/09/19 Authorised
Loqtorzi Human Toripalimab Toripalimab EMEA/H/C/006120 TMC Pharma (EU) Limited 2024/09/19 Authorised
Anzupgo Human Delgocitinib Delgocitinib EMEA/H/C/006109 LEO Pharma A/S 2024/09/19 Authorised
Vyloy Human Zolbetuximab Zolbetuximab EMEA/H/C/005868 Astellas Pharma Europe B.V. 2024/09/19 Authorised

数据库说明：

©2006-2024 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase